Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC)

被引:53
|
作者
Nakagawa, T
Otake, Y
Yanagihara, K
Miyahara, R
Ishikawa, S
Fukushima, M
Wada, H
Tanaka, F
机构
[1] Kyoto Univ, Fac Med, Dept Thorac Surg, Sakyo Ku, Kyoto 6068507, Japan
[2] Taiho Pharmaceut Co Ltd, Inst Appl Oncol, Hanno, Saitam 3578527, Japan
关键词
thymidylate synthase; non-small cell lung cancer; cell proliferation;
D O I
10.1016/j.lungcan.2003.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many experimental studies have revealed that enhanced thymidylate synthase (TS) expression is significantly correlated with higher proliferative activity of tumor cells, which may account for a poor prognosis of high-TS patients. However, only a few clinical studies have focused on the correlation between TS status and cell proliferation. Therefore, we assessed the correlation between TS expression and proliferative index (PI) as a marker of cell proliferation or p53 status in a total of 109 patients with completely resected pathologic stage I, non-small cell lung cancer (NSCLC). PI was defined as the percentage of tumor cells with positive staining against proliferative cell nuclear antigen (PCNA). The mean PIs of TS-high and TS-low tumors were 48.2% and 34.4% respectively, showing a significantly higher proliferative activity of TS-high tumor (P = 0.020); when stratified according to histological type, the difference was significant in adenocarcinoma (P = 0.038), but not in squamous cell carcinoma. There was no significant correlation between TS expression and p53 status. In conclusion, tumor cells with higher TS expression have higher proliferative activity in NSCLC, especially in adenocarcinoma. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 50 条
  • [41] The Pemetrexed-Containing Treatments in the Non-small Cell Lung Cancer, Is -/Low Thymidylate Synthase Expression Better than plus /High Thymidylate Synthase Expression? A Meta-analysis
    Wang, Lei
    Wang, Rui
    Pan, Yunjian
    Sun, Yihua
    Zhang, Jie
    Chen, Haiquan
    CHEST, 2014, 145 (03)
  • [42] THYMIDYLATE SYNTHASE EXPRESSION CAN GUIDE ANTI-CANCER DRUG SELECTION FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    Shimizu, Tetsuo
    Nakanishi, Yoko
    Nakagawa, Yoshiko
    Tsujino, Ichiro
    Takahashi, Noriaki
    Nemoto, Norimichi
    Hashimoto, Shu
    RESPIROLOGY, 2013, 18 : 7 - 7
  • [43] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Ramírez, JL
    Sancho, E
    Núñez, L
    Sánchez, JJ
    Balañá, C
    López, P
    Martín, C
    Monzó, M
    Rosell, R
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S39 - S39
  • [44] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Pifarre, A
    Monzo, M
    Martin, C
    Sanchez, JJ
    Barnadas, A
    Rosell, R
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [45] The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than plus /high thymidylate synthase expression: a meta-analysis
    Wang, Lei
    Wang, Rui
    Pan, Yunjian
    Sun, Yihua
    Zhang, Jie
    Chen, Haiquan
    BMC CANCER, 2014, 14
  • [46] Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer
    Jan Nyrop Jakobsen
    Eric Santoni-Rugiu
    Jens Benn Sørensen
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 645 - 652
  • [47] Thymidylate synthase protein expression levels remain stable during paclitaxel and carboplatin treatment in non-small cell lung cancer
    Jakobsen, Jan Nyrop
    Santoni-Rugiu, Eric
    Sorensen, Jens Benn
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (04) : 645 - 652
  • [48] Thymidylate Synthase Expression in High-Grade Neuroendocrine and Non-Small Cell Lung Cancer Histotypes-Is it Ready for Primetime?
    Reidy-Lagunes, Diane
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (01) : 10 - 10
  • [49] Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
    Siddiqui, Mohammad Aarif
    Gollavilli, Paradesi Naidu
    Ramesh, Vignesh
    Parma, Beatrice
    Schwab, Annemarie
    Vazakidou, Maria Eleni
    Natesan, Ramakrishnan
    Saatci, Ozge
    Rapa, Ida
    Bironzo, Paolo
    Schuhwerk, Harald
    Asangani, Irfan Ahmed
    Sahin, Ozgur
    Volante, Marco
    Ceppi, Paolo
    BRITISH JOURNAL OF CANCER, 2021, 124 (01) : 281 - 289
  • [50] Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
    Mohammad Aarif Siddiqui
    Paradesi Naidu Gollavilli
    Vignesh Ramesh
    Beatrice Parma
    Annemarie Schwab
    Maria Eleni Vazakidou
    Ramakrishnan Natesan
    Ozge Saatci
    Ida Rapa
    Paolo Bironzo
    Harald Schuhwerk
    Irfan Ahmed Asangani
    Ozgur Sahin
    Marco Volante
    Paolo Ceppi
    British Journal of Cancer, 2021, 124 : 281 - 289